Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-25
1997-06-17
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514214, 514221, 514299, 514306, 514248, 5142272, 540567, 540593, 540460, 540461, 544 47, 544235, 546138, 546183, A61K 3155, C07D48704, C07D51304, C07D47104
Patent
active
056397453
ABSTRACT:
Disclosed are compounds, compositions and methods for inhibiting interleukin-1.beta. protease activity. The compounds, bicyclic derivatives of aldehydes and .alpha.-substituted methyl ketones, have the formula (A) set out herein.
REFERENCES:
patent: 4341781 (1982-07-01), Hassall et al.
patent: 4399136 (1983-08-01), Hassall et al.
patent: 4988771 (1991-01-01), Angebauer et al.
Chaturvedula Prasad V.
Dolle Roland E.
Ross Tina Morgan
Schmidt Stanley J.
Balogh Imre
Davis William J.
Dupont Paul
Grumbling Matthew V.
Sanofi
LandOfFree
Fused-bicyclic lactams as interleukin-1.beta. converting enzyme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused-bicyclic lactams as interleukin-1.beta. converting enzyme , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused-bicyclic lactams as interleukin-1.beta. converting enzyme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157892